Lunds universitet, Medicinska fakulteten, Inst för laboratoriemedicin

Lund University was founded in 1666 and is repeatedly ranked among the world’s top universities. The University has around 47 000 students and more than 8 800 staff based in Lund, Helsingborg and Malmö. We are united in our efforts to understand, explain and improve our world and the human condition.

Lund University welcomes applicants with diverse backgrounds and experiences. We regard gender equality and diversity as a strength and an asset.

The research group

In the research group for Cell reprogramming in hematopoiesis and immunity, research is conducted to understand the molecular determinants underlying cellular reprogramming and hematopoietic specification. Research has been at the forefront in this area for several years. The group is led by Professor Filipe Pereira and consists of both research and technical staff. The business is located at the Biomedical Center in Lund. Here you can read more about our exciting research.

Within the research group, we cherish a workplace that is experienced as evolving and stimulating for all employees.

We are hereby seeking a driven associate researcher to work with the group on reprogramming of cells, hematopoiesis and developing immunotherapeutic strategies for cells and genes. The employment is limited to two years of 50% with the desired date of admission on 15 February or by agreement.

Work duties and areas of responsibility
As associate researcher within the research group you are responsible for work on the development of a novel strategy for the reprogramming of fibroblasts into functional antigen presenting dendritic cells. The goal is to provide support for the development of novel cell and gene therapies for cancer and viral infections. The successful candidate will be performing lentiviral productions, transcriptional and epigenetic profiling experiments and detailed functional characterization of reprogrammed cells. These will be followed by in vivo experimentation in mouse tumor models. The candidate will also develop the drug development strategy for the translation of the technology. The successful candidate will be responsible for engaging and maintaining collaborations, general laboratory organization as well writing scientific publications and grant applications.

Qualifications

The following is required for the position:

  • A PhD degree in Medicine, Biomedicine, Biology or similar.
  • Knowledge on lentiviral particle generation, cell culture techniques and tumor models in mice.
  • Knowledge of cell fate reprogramming and immunology.
  • The ability to work independently in the laboratory.
  • The ability to supervise and provide training to young students.
  • The ability to organize and help on the administration of the laboratory.
  • The ability to write scientific publications and grant applications.
  • The ability to communicate fluently in English, both in writing and speaking.

Emphasis is put on personal suitability. The work duties require the ability to communicate well and the ability to work well both independantly and together with a group. 

The following is desirable for the position:

  • A PharmD degree.
  • Experience with transcription-factor mediated cell reprogramming.
  • Experience with dendritic cell biology.

Instructions for the application

The application should include both a personal letter where you describe your fullfillance of the wanted qualifications, a resume and a PhD certificate.

Type of employment Temporary position
Contract type Part-time
First day of employment 2020-02-15
Salary Monthly
Number of positions 1
Full-time equivalent 50
City Lund
County Skåne län
Country Sweden
Reference number PA2020/27
Contact
  • Filipe Pereira, recruiting manager, +46462224919
  • Tilde Lindgren, human resources coordinator, 046-2220000
Published 09.Jan.2020
Last application date 23.Jan.2020 11:59 PM CET

Return to job vacancies